Trambaiolli, Lucas
Maffei, Chiara
Dann, Evan
Biazoli Jr, Claudinei
Bezgin, Gleb
Yendiki, Anastasia
Haber, Suzanne
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K99-MH130648, P50-MH106435, R01-MH045573)
Jonathan Edward Brooking Mental Health Research Fellowship
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01-EB021265, R01-EB021265, R01-EB021265)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS119911, R01-NS119911, R01-NS119911)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Article History
Received: 4 June 2024
Revised: 16 July 2024
Accepted: 23 July 2024
First Online: 5 August 2024
Competing interests
: LT is an Editorial Intern for <i>Neuropsychopharmacology</i>. The remaining authors have nothing to disclose.